Tenofovir Disoproxil Fumarate(Tdf) Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral tablets
Available Strengths: 300 mg
Reference Brands: Viread® (EU & US)
Category:
Hepatitis
Tenofovir Disoproxil Fumarate (TDF) is a 300 mg oral antiviral used to treat chronic Hepatitis B and HIV-1 infections. It inhibits viral reverse transcriptase, reducing viral replication and disease progression. Marketed as Viread®, it is approved by FDA and EMA and widely used in the US and EU. TDF is a key drug for pharma B2B suppliers and healthcare professionals managing viral infections.
Tenofovir Disoproxil Fumarate(TDF) tablets is available in Oral tablets
and strengths such as 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tenofovir Disoproxil Fumarate(TDF) tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tenofovir Disoproxil Fumarate(TDF) tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tenofovir Disoproxil Fumarate (TDF) is a potent nucleotide reverse transcriptase inhibitor used to treat chronic Hepatitis B virus (HBV) infection and HIV-1. Available as oral tablets at 300 mg strength, TDF effectively blocks viral replication by inhibiting viral reverse transcriptase enzymes, reducing viral load and preventing disease progression. Marketed under the brand name Viread® by Gilead Sciences, it is approved by the US FDA and EMA. Widely prescribed in both the EU and US, Tenofovir Disoproxil Fumarate is essential for pharma B2B suppliers and healthcare providers managing viral hepatitis and HIV therapies.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing